LFST 📈 Lifestance Health - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US53228F1012
LFST: Mental, Health, Services, Therapy, Testing, Treatment, Counseling
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona. Web URL: https://lifestance.com
Additional Sources for LFST Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
LFST Stock Overview
| Market Cap in USD | 2,809m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Equipment |
| IPO / Inception | 2021-06-10 |
LFST Stock Ratings
| Growth 5y | -59.9% |
| Fundamental | -17.4% |
| Dividend | - |
| Rel. Strength Industry | -105 |
| Analysts | 3.83/5 |
| Fair Price Momentum | 6.34 USD |
| Fair Price DCF | 2.20 USD |
LFST Dividends
No Dividends PaidLFST Growth Ratios
| Growth Correlation 3m | 64.2% |
| Growth Correlation 12m | 15% |
| Growth Correlation 5y | -56.7% |
| CAGR 5y | -26.67% |
| CAGR/Mean DD 5y | -0.38 |
| Sharpe Ratio 12m | 0.12 |
| Alpha | -38.55 |
| Beta | 1.35 |
| Volatility | 48.78% |
| Current Volume | 2266.3k |
| Average Volume 20d | 1501.6k |
What is the price of LFST stocks?
As of December 21, 2024, the stock is trading at USD 7.29 with a total of 2,266,311 shares traded.
Over the past week, the price has changed by +1.67%, over one month by +0.97%, over three months by +7.05% and over the past year by -0.27%.
As of December 21, 2024, the stock is trading at USD 7.29 with a total of 2,266,311 shares traded.
Over the past week, the price has changed by +1.67%, over one month by +0.97%, over three months by +7.05% and over the past year by -0.27%.
Is Lifestance Health a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Lifestance Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -17.39 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LFST as of December 2024 is 6.34. This means that LFST is currently overvalued and has a potential downside of -13.03%.
Neither. Based on ValueRay Fundamental Analyses, Lifestance Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -17.39 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LFST as of December 2024 is 6.34. This means that LFST is currently overvalued and has a potential downside of -13.03%.
Is LFST a buy, sell or hold?
Lifestance Health has received a consensus analysts rating of 3.83. Therefor, it is recommend to buy LFST.
Lifestance Health has received a consensus analysts rating of 3.83. Therefor, it is recommend to buy LFST.
- Strong Buy: 2
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecast for LFST stock price target?
According to ValueRays Forecast Model, LFST Lifestance Health will be worth about 7.1 in December 2025. The stock is currently trading at 7.29. This means that the stock has a potential downside of -2.88%.
According to ValueRays Forecast Model, LFST Lifestance Health will be worth about 7.1 in December 2025. The stock is currently trading at 7.29. This means that the stock has a potential downside of -2.88%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 8.3 | 13.9% |
| Analysts Target Price | 9.5 | 30.3% |
| ValueRay Target Price | 7.1 | -2.9% |